News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
505,666 Results
Type
Article (36120)
Company Profile (164)
Press Release (469382)
Multimedia
Podcasts (75)
Webinars (11)
Section
Business (145447)
Career Advice (1629)
Deals (28200)
Drug Delivery (107)
Drug Development (71219)
Employer Resources (130)
FDA (12078)
Job Trends (11099)
News (262982)
Policy (28809)
Tag
Academia (2025)
Academic (1)
Accelerated approval (4)
Adcomms (22)
Allergies (77)
Alliances (45739)
ALS (80)
Alzheimer's disease (1256)
Antibody-drug conjugate (ADC) (137)
Approvals (12066)
Artificial intelligence (218)
Autoimmune disease (19)
Automation (9)
Bankruptcy (263)
Best Places to Work (8839)
BIOSECURE Act (21)
Biosimilars (93)
Biotechnology (110)
Bladder cancer (68)
Brain cancer (29)
Breast cancer (239)
Cancer (2012)
Cardiovascular disease (146)
Career advice (1357)
Career pathing (29)
CAR-T (144)
Cell therapy (387)
Cervical cancer (17)
Clinical research (58055)
Collaboration (806)
Company closure (1)
Compensation (515)
Complete response letters (23)
COVID-19 (2565)
CRISPR (34)
C-suite (193)
Cystic fibrosis (79)
Data (1974)
Decentralized trials (1)
Denatured (21)
Depression (40)
Diabetes (257)
Diagnostics (4237)
Digital health (11)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (101)
Drug pricing (110)
Drug shortages (29)
Duchenne muscular dystrophy (94)
Earnings (54698)
Editorial (45)
Employer branding (18)
Employer resources (116)
Events (70823)
Executive appointments (541)
FDA (13197)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (624)
Gene editing (86)
Generative AI (16)
Gene therapy (284)
GLP-1 (766)
Government (4386)
Grass and pollen (5)
Guidances (127)
Healthcare (13176)
Huntington's disease (20)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (26)
Infectious disease (2715)
Inflammatory bowel disease (113)
Inflation Reduction Act (7)
Influenza (55)
Intellectual property (83)
Interviews (283)
IPO (12979)
IRA (43)
Job creations (2623)
Job search strategy (1171)
Kidney cancer (8)
Labor market (38)
Layoffs (406)
Leadership (19)
Legal (7531)
Liver cancer (63)
Lung cancer (285)
Lymphoma (144)
Machine learning (8)
Management (41)
Manufacturing (301)
MASH (68)
Medical device (7173)
Medtech (7175)
Mergers & acquisitions (15739)
Metabolic disorders (684)
Multiple sclerosis (70)
NASH (21)
Neurodegenerative disease (88)
Neuropsychiatric disorders (28)
Neuroscience (1739)
NextGen: Class of 2025 (4311)
Non-profit (3021)
Now hiring (34)
Obesity (377)
Opinion (240)
Ovarian cancer (69)
Pain (68)
Pancreatic cancer (77)
Parkinson's disease (131)
Partnered (16)
Patents (198)
Patient recruitment (86)
Peanut (39)
People (38572)
Pharmaceutical (51)
Pharmacy benefit managers (16)
Phase I (17710)
Phase II (25519)
Phase III (19688)
Pipeline (1227)
Policy (157)
Postmarket research (2258)
Preclinical (7304)
Press Release (59)
Prostate cancer (93)
Psychedelics (32)
Radiopharmaceuticals (239)
Rare diseases (331)
Real estate (3825)
Recruiting (53)
Regulatory (18919)
Reports (37)
Research institute (1807)
Resumes & cover letters (236)
Rett syndrome (4)
RNA editing (3)
RSV (48)
Schizophrenia (71)
Series A (106)
Series B (68)
Service/supplier (9)
Sickle cell disease (44)
Special edition (19)
Spinal muscular atrophy (147)
Sponsored (22)
Startups (2553)
State (2)
Stomach cancer (13)
Supply chain (64)
Tariffs (48)
The Weekly (53)
Vaccines (769)
Venture capitalists (37)
Weight loss (266)
Women's health (20)
Worklife (15)
Date
Today (23)
Last 7 days (766)
Last 30 days (2362)
Last 365 days (25957)
2025 (9415)
2024 (28116)
2023 (31796)
2022 (41062)
2021 (44237)
2020 (41351)
2019 (33780)
2018 (25472)
2017 (24862)
2016 (23142)
2015 (26890)
2014 (20840)
2013 (16740)
2012 (17712)
2011 (18846)
2010 (17566)
Location
Africa (671)
Alabama (40)
Alaska (3)
Arizona (116)
Arkansas (7)
Asia (33635)
Australia (5389)
California (4939)
Canada (1549)
China (511)
Colorado (209)
Connecticut (209)
Delaware (141)
Europe (76138)
Florida (699)
Georgia (161)
Hawaii (1)
Idaho (35)
Illinois (382)
India (26)
Indiana (257)
Iowa (11)
Japan (158)
Kansas (82)
Kentucky (20)
Louisiana (11)
Maine (35)
Maryland (800)
Massachusetts (3724)
Michigan (139)
Minnesota (209)
Mississippi (1)
Missouri (58)
Montana (22)
Nebraska (16)
Nevada (49)
New Hampshire (26)
New Jersey (1544)
New Mexico (19)
New York (1469)
North Carolina (743)
North Dakota (5)
Northern California (2269)
Ohio (142)
Oklahoma (8)
Oregon (19)
Pennsylvania (1026)
Puerto Rico (12)
Rhode Island (29)
South America (933)
South Carolina (14)
South Dakota (1)
Southern California (1847)
Tennessee (56)
Texas (630)
United States (18229)
Utah (115)
Virginia (111)
Washington D.C. (52)
Washington State (395)
West Virginia (2)
Wisconsin (39)
505,666 Results for "r biopharm ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Special edition
Deep Dive: Biopharma In Turmoil As Peter Marks Forced Out of FDA
Peter Marks, the venerable head of the FDA’s Center for Biologics Evaluation and Research, has been forced out. In this special edition of BioPharm Executive,
BioSpace
takes a deep dive into the instability of the HHS.
May 9, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Viromed Medical AG: UMECO Group Acquires Exclusive Marketing Rights in Asia for Cold Plasma Medical Devices ViroCAP(R) and PulmoPlas(R)
April 2, 2025
·
4 min read
Clinical research
Pharma R&D Returns Grow Again, But Deloitte Warns Progress is ‘Fragile’
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
March 27, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Kexing Biopharm Participates in the 17th Biotech Showcase, with Multiple Innovation Pipelines Gaining Attention
January 24, 2025
·
4 min read
Policy
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
On the evening of May 5, Kexing Biopharm announced it had obtained a “Certificate of GMP Compliance of a Manufacturer” granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency regulations.
May 10, 2024
·
2 min read
Press Releases
Viromed Medical AG Reports Promising Study Results for PulmoPlas(R) in Intensive Care Unit Ventilator-Associated Pneumonia Patients
March 17, 2025
·
4 min read
Drug Development
R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm
Recently, Kexing Biopharm announced that the Phase III clinical trial of Human Interferon α1b Inhalation Solution developed by its wholly-owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd., had completed the enrollment of first patient and dosing.
April 9, 2024
·
2 min read
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
TC BioPharm plc announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,750,000 of the Company’s American Depositary Shares originally issued in December 2023 with an exercise price of £1.5814 per ADS and a term of five years.
May 6, 2024
·
4 min read
PharmAbcine’s U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024
PharmAbcine, Inc. announced that its U.S. subsidiary, Wincal Biopharm, Inc. (“WincalBio”), gained agreat attention at the world’s largest ophthalmology conference, Association for Research in Vision and Ophthalmology 2024 (ARVO 2024), when they presented the preclinical data of the eye drop formulation.
May 22, 2024
·
2 min read
Press Releases
Bacteria in Our Aging Guts Can Elevate Risk of Leukemia
April 24, 2025
·
7 min read
1 of 50,567
Next
